Results 11 to 20 of about 92,046 (305)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer

Journal for ImmunoTherapy of Cancer, 2021
A number of immunotherapies have been developed and adopted for the treatment of urothelial cancer (encompassing cancers arising from the bladder, urethra, or renal pelvis).
Gary D Steinberg, Neal Shore, Petros Grivas, Matthew D Galsky, Elizabeth R Plimack, Shilpa Gupta, Arjun V Balar, Peter C Black, Matthew T Campbell, Gail S Dykstra, Christoper J Hoimes, Lidia P Lopez, Joshua J Meeks, Jonathan E Rosenberg, Ashish M Kamat   +14 more
doaj   +1 more source

Expression of LDL receptor-related proteins (LRPs) in common solid malignancies correlates with patient survival [PDF]

, 2017
LDL receptor-related proteins (LRPs) are transmembrane receptors involved in endocytosis, cell-signaling, and trafficking of other cellular proteins. Considerable work has focused on LRPs in the fields of vascular biology and neurobiology.
Gilder, Andrew S., Gonias, Steven L., Karimi-Mostowfi, Nicki, Mantuano, Elisabetta, Murray, Sarah S.   +4 more
core   +8 more sources

A radiological complete response to pembrolizumab in a patient with metastatic upper urinary tract urothelial cancer and Lynch syndrome

IJU Case Reports, 2023
Introduction In Lynch syndrome, urothelial cancer is the third most common cancer, following colorectal and endometrial cancers. Little is known, however, about the efficacy of immune checkpoint inhibitors in the treatment of metastatic urothelial cancer
Ryosuke Oki, Tetsuya Urasaki, Arisa Ueki, Kentaro Inamura, Yoshinobu Komai, Shunji Takahashi, Junji Yonese, Takeshi Yuasa   +7 more
doaj   +1 more source

Second line therapy for metastatic urothelial carcinoma. Clinical case of vinflunine use

Медицинский совет, 2022
Urothelial cancer occupies a significant place in the routine practice of cancer treatment. Systemic antitumor treatment of patients with metastatic urothelial cancer in the first line is currently well studied, has its own standards, implemented in ...
A. A. Gritskevich, A. Yu. Popov, I. G. Rusakov, E. K. Vozniy, V. A. Makarov, D. I. Gridnev, T. P. Baitman, S. V. Mishugin, I. V. Novikova, S. V. Khromova   +9 more
doaj   +1 more source

Urothelial bladder carcinoma metastasizing to the eye: a systematic review and case report [PDF]

, 2019
The eye is a rare site for disseminated malignancies; nevertheless, several tumors may metastasize to ocular structures. Few cases of urothelial and bladder cancer with eye involvement have been described in the literature thus far.
Brunelli, Matteo, Coppola, Giulia, Coppola, Luigi, D'Andrea, Mario Rosario, de Santis, Elena, Di Raimo, Tania, Giordano, Guido, Manfrin, Erminia, Olivieri, Nunzio, Pancione, Massimo, Parcesepe, Pietro, Remo, Andrea, Scarpa, Aldo   +12 more
core   +1 more source

Dynamic Change in p63 Protein Expression during Implantation of Urothelial Cancer Clusters

Neoplasia: An International Journal for Oncology Research, 2015
Although the dissemination of urothelial cancer cells is supposed to be a major cause of the multicentricity of urothelial tumors, the mechanism of implantation has not been well investigated.
Takahiro Yoshida, Hiroaki Okuyama, Masashi Nakayama, Hiroko Endo, Yasuhiko Tomita, Norio Nonomura, Kazuo Nishimura, Masahiro Inoue   +7 more
doaj   +1 more source

Functional Genomics Profiling of Bladder Urothelial Carcinoma MicroRNAome as a Potential Biomarker. [PDF]

, 2018
Though bladder urothelial carcinoma is the most common form of bladder cancer, advances in its diagnosis and treatment have been modest in the past few decades.
Li, Wei Tse, Nguyen, Vincent, Ongkeko, Weg M, Wang-Rodriguez, Jessica, Zheng, Hao   +4 more
core   +2 more sources

Prognostic and Diagnostic Significance of Platelet Indices in Patients with Urothelial Carcinoma

Uro, 2021
Some prognostic markers have been shown to determine the course and survival of Urothelial Cancer. A cross-sectional retrospective study, specifically looking at the role that various indices related to platelets—namely Mean Platelet Volume (MPV ...
Gulshan Kumar Mukhiya, Geeta W Mukhiya, Neelam Jain, Khushi Mukhiya   +3 more
doaj   +1 more source

Precision oncology in urothelial cancer [PDF]

ESMO Open, 2020
Genomics-driven, precision medicine has been adopted in virtually every tumour type and underlies the significant advances in cancer management to date. The paradigm shift from the indiscriminate use of chemotherapeutics, to strategies that harness our mechanistic knowledge of cancer biology has led to profound clinical benefit for patients, and will ...
Elizabeth Liow, Ben Tran
openaire   +4 more sources

Prioritizing potential circRNA biomarkers for bladder cancer and bladder urothelial cancer based on an ensemble model

Frontiers in Genetics, 2022
Bladder cancer is the most common cancer of the urinary system. Bladder urothelial cancer accounts for 90% of bladder cancer. These two cancers have high morbidity and mortality rates worldwide.
Qiongli Su, Qiuhong Tan, Xin Liu, Ling Wu   +3 more
doaj   +1 more source